Generate protein structures with predictive AI.
Workloads
Generative AI
Industries
Healthcare and Life Sciences
Business Goal
Innovation
Return on Investment
Products
NVIDIA BioNeMo
The prediction of protein structures is an important frontier in computational biology because it enables a deeper understanding of biological functions and mechanisms. It’s crucial for innovations in drug design, disease comprehension, and the development of novel biotechnological products with various industrial applications. Traditionally, the immense diversity of possible protein structures and the high costs and lengthy timelines associated with experimental methods for protein structure prediction posed significant barriers. Today, these challenges are being met head-on by integrating accelerated computing resources and advanced predictive AI models, such as AlphaFold, ESMFold, and Rosetta.
These sophisticated tools have revolutionized our approach to protein structure prediction by enabling the rapid generation of protein models that often have angstrom-scale accuracy. This technological leap saves valuable time and resources while enhancing our understanding of protein functions and interactions.
NVIDIA’s accelerated computing and AI platform for drug discovery, BioNeMo™, enables researchers and application developers to: